PT2571994T - Produção de dha e de outros lc-pufas em plantas - Google Patents

Produção de dha e de outros lc-pufas em plantas

Info

Publication number
PT2571994T
PT2571994T PT117841148T PT11784114T PT2571994T PT 2571994 T PT2571994 T PT 2571994T PT 117841148 T PT117841148 T PT 117841148T PT 11784114 T PT11784114 T PT 11784114T PT 2571994 T PT2571994 T PT 2571994T
Authority
PT
Portugal
Prior art keywords
dha
plants
purposes
production
Prior art date
Application number
PT117841148T
Other languages
English (en)
Portuguese (pt)
Inventor
A Walsh Terence
Owens Merlo Ann
Gachotte Daniel
Gordon Roessler Paul
Bevan Scott
M Kuner Jerry
G Metz James
Original Assignee
Dsm Ip Assets Bv
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv, Dow Agrosciences Llc filed Critical Dsm Ip Assets Bv
Publication of PT2571994T publication Critical patent/PT2571994T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6432—Eicosapentaenoic acids [EPA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6434—Docosahexenoic acids [DHA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
PT117841148T 2010-05-17 2011-05-17 Produção de dha e de outros lc-pufas em plantas PT2571994T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34553710P 2010-05-17 2010-05-17

Publications (1)

Publication Number Publication Date
PT2571994T true PT2571994T (pt) 2018-03-14

Family

ID=44992026

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117841148T PT2571994T (pt) 2010-05-17 2011-05-17 Produção de dha e de outros lc-pufas em plantas

Country Status (25)

Country Link
US (5) US20130150599A1 (enExample)
EP (3) EP3354739A1 (enExample)
JP (1) JP6059138B2 (enExample)
KR (1) KR102184432B1 (enExample)
CN (2) CN105296511A (enExample)
AR (1) AR081201A1 (enExample)
AU (1) AU2011256209B2 (enExample)
BR (1) BR112012029255A2 (enExample)
CA (2) CA2799559C (enExample)
CL (1) CL2012003210A1 (enExample)
EA (1) EA201291223A1 (enExample)
ES (1) ES2656217T3 (enExample)
HU (1) HUE036182T2 (enExample)
IL (1) IL223045A0 (enExample)
MX (1) MX345243B (enExample)
MY (1) MY165098A (enExample)
NO (1) NO2571994T3 (enExample)
NZ (1) NZ604479A (enExample)
PH (1) PH12012502267A1 (enExample)
PL (1) PL2571994T3 (enExample)
PT (1) PT2571994T (enExample)
SG (1) SG185572A1 (enExample)
TW (1) TW201144442A (enExample)
UA (1) UA116613C2 (enExample)
WO (1) WO2011146524A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11236351B2 (en) * 2010-05-17 2022-02-01 Dow Agrosciences Llc Production of DHA and other LC PUFAs in plants
TW201144442A (en) * 2010-05-17 2011-12-16 Dow Agrosciences Llc Production of DHA and other LC-PUFAs in plants
WO2012091651A1 (en) * 2010-12-30 2012-07-05 Telefonaktiebolaget L M Ericsson (Publ) Methods and apparatuses for enabling power back-off indication in phr in a telecommunications system
TW201307553A (zh) * 2011-07-26 2013-02-16 Dow Agrosciences Llc 在植物中生產二十二碳六烯酸（ｄｈａ）及其他長鏈多元不飽和脂肪酸（ｌｃ－ｐｕｆａ）之技術
EP3388516A1 (en) 2011-10-19 2018-10-17 Massachusetts Institute Of Technology Engineered microbes and methods for microbial oil production
AU2012362825B2 (en) * 2011-12-30 2016-07-21 Corteva Agriscience Llc DHA retention during canola processing
HUE033766T2 (en) 2012-06-15 2018-01-29 Commw Scient Ind Res Org Production of long chain polyunsaturated fatty acids in plant cells
AR091774A1 (es) * 2012-07-16 2015-02-25 Dow Agrosciences Llc Proceso para el diseño de las secuencias de adn repetidas, largas, divergentes de codones optimizados
CN110876413A (zh) * 2012-09-11 2020-03-13 美国陶氏益农公司 与dha共混的ω-9芸苔油
BR112015023058B1 (pt) 2013-03-15 2023-04-11 Lisa Hollister Cassete de expressão
WO2014152986A2 (en) * 2013-03-15 2014-09-25 Hollister Lisa Genetically modified plants that are herbivore-resistant
CA2926197A1 (en) 2013-10-04 2015-04-09 Dow Agrosciences Llc Zea mays metallothionein-like regulatory elements and uses thereof
BR102014025574A2 (pt) 2013-10-15 2015-09-29 Dow Agrosciences Llc elementos regulatórios de zea mays e usos dos mesmos
BR102014025499A2 (pt) 2013-10-15 2015-09-29 Dow Agrosciences Llc elementos regulatórios de zea mays e uso dos mesmos
BR102014029437A2 (pt) 2013-11-26 2015-07-07 Dow Agrosciences Llc Produção de ácidos graxos ômega-3 polinsaturados de cadeia longa em culturas oleaginosas por uma pufa sintase de traustoquitrídio
EA037817B1 (ru) 2013-12-18 2021-05-25 Коммонвелт Сайнтифик Энд Индастриэл Рисерч Организэйшн Экстрагированный растительный липид, содержащий длинноцепочечные полиненасыщенные жирные кислоты
TW201527312A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子（一）
TW201527313A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子（二）
TW201527314A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子（三）
TW201527316A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子（五）
BR102015000943A2 (pt) 2014-01-17 2016-06-07 Dow Agrosciences Llc expressão aumentada de proteína em planta
US10087430B2 (en) 2014-01-28 2018-10-02 Dsm Ip Assets B.V. Factors for the production and accumulation of polyunsaturated fatty acids (PUFAS) derived from PUFA synthases
TW201538518A (zh) 2014-02-28 2015-10-16 Dow Agrosciences Llc 藉由嵌合基因調控元件所賦予之根部特異性表現
CA2953008C (en) 2014-06-27 2024-03-19 Nuseed Pty Ltd Lipid comprising docosapentaenoic acid
US11484560B2 (en) 2014-11-14 2022-11-01 Basf Plant Science Company Gmbh Stabilising fatty acid compositions
BR112017021703B1 (pt) 2015-04-15 2023-11-28 Corteva Agriscience Llc Promotor de planta para expressão de transgene
EP3283633A2 (en) 2015-04-15 2018-02-21 Dow AgroSciences LLC Plant promoter for transgene expression
TW201718862A (zh) 2015-09-22 2017-06-01 Dow Agrosciences Llc 用於轉殖基因表現之植物啟動子及３’ｕｔｒ
TW201718861A (zh) 2015-09-22 2017-06-01 道禮責任有限公司 用於轉殖基因表現之植物啟動子及３’ｕｔｒ
UY36957A (es) 2015-10-22 2017-05-31 Dow Agrosciences Llc Promotor de vegetales para la expresión transgénica
US20170121726A1 (en) 2015-11-04 2017-05-04 Dow Agrosciences Llc Plant promoter for transgene expression
JP6966040B2 (ja) 2016-05-12 2021-11-10 ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. 微細藻類中でのオメガ−３多価不飽和脂肪酸産生を増加させる方法
IL296501B2 (en) * 2016-06-16 2025-07-01 Nuseed Nutritional Australia Pty Ltd Canola NS–B50027–4
CN110291199B (zh) 2016-10-03 2023-12-22 美国陶氏益农公司 用于转基因表达的植物启动子
CN109996436B (zh) 2016-10-03 2023-09-29 科迪华农业科技有限责任公司 用于转基因表达的植物启动子
WO2019005183A1 (en) 2017-06-28 2019-01-03 Dow Agrosciences Llc PLANT PROMOTER FOR TRANSGENIC EXPRESSION
EP3676383B1 (en) 2017-08-31 2024-06-19 Corteva Agriscience LLC Compositions and methods for expressing transgenes using regulatory elements from chlorophyll binding ab genes
BR112021002299A2 (pt) * 2018-08-10 2021-05-04 Kyowa Hakko Bio Co., Ltd micro-organismo produzindo ácido graxo poli-insaturado e método para produzir ácido graxo poli-insaturado
EP3835410A4 (en) * 2018-08-10 2022-05-18 Kyowa Hakko Bio Co., Ltd. MICROORGANISM PRODUCING EICOSAPENTAENOIC ACID AND METHOD FOR PRODUCTION OF EICOSAPENTAENOIC ACID
CN109852724A (zh) * 2019-04-03 2019-06-07 深圳出入境检验检疫局食品检验检疫技术中心 转基因油菜品系oxy235检测方法、试剂和试剂盒
CA3237962A1 (en) 2021-11-09 2023-05-19 Benson Hill, Inc. Promoter elements for improved polynucleotide expression in plants
US20250051792A1 (en) 2021-12-15 2025-02-13 Benson Hill, Inc. Spatio-temporal promoters for polynucleotide expression in plants
PE20251265A1 (es) * 2022-06-27 2025-05-07 Monsanto Technology Llc Evento transgenico de soja gm_csm63770 y metodos para su deteccion y sus usos
WO2024127362A1 (en) 2022-12-15 2024-06-20 Benson Hill, Inc. Spatio-temporal promoters for polynucleotide expression in plants
WO2025238190A1 (en) 2024-05-15 2025-11-20 Dsm Ip Assets B.V. Spray-dried powders having high pufa content

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8300698A (nl) 1983-02-24 1984-09-17 Univ Leiden Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
US5420034A (en) 1986-07-31 1995-05-30 Calgene, Inc. Seed-specific transcriptional regulation
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5693507A (en) 1988-09-26 1997-12-02 Auburn University Genetic engineering of plant chloroplasts
US5451513A (en) 1990-05-01 1995-09-19 The State University of New Jersey Rutgers Method for stably transforming plastids of multicellular plants
AU669478B2 (en) 1991-04-09 1996-06-13 Unilever Plc Plant promoter involved in controlling lipid biosynthesis in seeds
US6210700B1 (en) 1997-01-14 2001-04-03 Novartis Nutrition Ag Enhancement of transplant graft survival through nutritional immunomodulation with omega-9 fatty acid dietary supplement therapy
IL133272A0 (en) 1997-06-04 2001-04-30 Calgene Llc Production of polyunsaturated fatty acid by expression of polyketide-like synthesis genes in plants
US6566583B1 (en) * 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
ES2325874T3 (es) * 1998-11-17 2009-09-22 Monsanto Technology Llc Plantas que matabolizan fosfonatos.
US8003772B2 (en) * 1999-01-14 2011-08-23 Martek Biosciences Corporation Chimeric PUFA polyketide synthase systems and uses thereof
US7247461B2 (en) 1999-01-14 2007-07-24 Martek Biosciences Corporation Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
US7211418B2 (en) 1999-01-14 2007-05-01 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US7217856B2 (en) 1999-01-14 2007-05-15 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US6784342B1 (en) 1999-08-04 2004-08-31 The University Of British Columbia Regulation of embryonic transcription in plants
DE69939944D1 (de) 1999-09-30 2009-01-02 Japan Tobacco Inc Vektoren zum transformieren von pflanzen
EP1283892A2 (en) 2000-05-24 2003-02-19 The University Of British Columbia Gene regulatory region that promotes early seed-specific transcription
EP1285073A2 (en) * 2000-05-24 2003-02-26 University of British Columbia Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme
US20040172682A1 (en) 2003-02-12 2004-09-02 Kinney Anthony J. Production of very long chain polyunsaturated fatty acids in oilseed plants
EP2218334B1 (en) * 2004-11-04 2016-09-28 Monsanto Technology LLC Processes for preparation of oil compositions
WO2006135866A2 (en) 2005-06-10 2006-12-21 Martek Biosciences Corporation Pufa polyketide synthase systems and uses thereof
WO2007016521A2 (en) * 2005-08-01 2007-02-08 Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Foods Canada Low fiber yellow canola seeds comprising high oleic, low linolenic oil
US7868228B2 (en) 2006-01-31 2011-01-11 Monsanto Technology Llc Phosphopantetheinyl transferases from bacteria
MX340759B (es) * 2006-03-15 2015-03-11 Dsm Ip Assets B V * Aceites de semillas vegetales que contienen ácidos grasos poli-insaturados.
TW200824582A (en) * 2006-08-29 2008-06-16 Martek Biosciences Corp Use of DPA(n-6) oils in infant formula
CN101951755A (zh) 2007-12-21 2011-01-19 加拿大国家研究委员会 来自藻类的二酰基甘油酰基转移酶2基因及其编码的蛋白质
CA2721879A1 (en) * 2008-04-25 2009-10-29 Basf Plant Science Gmbh Plant seed oil
EP2331695B1 (en) * 2008-08-26 2014-07-23 BASF Plant Science GmbH Nucleic acids encoding desaturases and modified plant oil
ES2717102T3 (es) * 2009-03-19 2019-06-19 Dsm Ip Assets Bv Moléculas de ácido nucleico de ácido graso poliinsaturado sintasas, y polipéptidos, composiciones y métodos de preparación y usos de los mismos
TW201144442A (en) * 2010-05-17 2011-12-16 Dow Agrosciences Llc Production of DHA and other LC-PUFAs in plants

Also Published As

Publication number Publication date
JP6059138B2 (ja) 2017-01-11
US20220170037A1 (en) 2022-06-02
US20180073036A1 (en) 2018-03-15
US11168332B2 (en) 2021-11-09
US20200362361A1 (en) 2020-11-19
CN105296511A (zh) 2016-02-03
CN103080319A (zh) 2013-05-01
IL223045A0 (en) 2013-02-03
CN103080319B (zh) 2015-11-25
US10669554B2 (en) 2020-06-02
KR20130109974A (ko) 2013-10-08
MX2012013401A (es) 2013-09-02
PL2571994T3 (pl) 2018-06-29
US12006504B2 (en) 2024-06-11
EP3517617A1 (en) 2019-07-31
EP3354739A1 (en) 2018-08-01
CA2799559A1 (en) 2011-11-24
EP2571994A4 (en) 2013-10-23
US20130150599A1 (en) 2013-06-13
JP2013529086A (ja) 2013-07-18
MX345243B (es) 2017-01-23
ES2656217T3 (es) 2018-02-26
EP2571994A1 (en) 2013-03-27
AU2011256209A1 (en) 2013-01-10
NZ604479A (en) 2014-10-31
MY165098A (en) 2018-02-28
UA116613C2 (uk) 2018-04-25
CA2799559C (en) 2022-06-28
HUE036182T2 (hu) 2018-06-28
WO2011146524A1 (en) 2011-11-24
HK1179652A1 (zh) 2013-10-04
EP2571994B1 (en) 2017-12-13
SG185572A1 (en) 2012-12-28
EA201291223A1 (ru) 2013-05-30
CL2012003210A1 (es) 2013-08-02
US20190010510A1 (en) 2019-01-10
TW201144442A (en) 2011-12-16
CA3161375A1 (en) 2011-11-24
PH12012502267A1 (en) 2013-02-11
AR081201A1 (es) 2012-07-04
NO2571994T3 (enExample) 2018-05-12
BR112012029255A2 (pt) 2015-09-08
AU2011256209B2 (en) 2016-12-22
KR102184432B1 (ko) 2020-12-01

Similar Documents

Publication Publication Date Title
PT2571994T (pt) Produção de dha e de outros lc-pufas em plantas
CL2014000194A1 (es) Produccion de dha y otras lc-pufas en plantas
BR112013004354A2 (pt) ativo de partículas compósitas e seu método de produção
PL2691443T3 (pl) Sprzężone lipomery i ich zastosowania
BR112013001592A2 (pt) artigo e método
PL3578201T3 (pl) Metody i kompozycje dla naturalnych komórek cytotoksycznych
BR112013010847A2 (pt) artigo e método
PL2755508T3 (pl) Artykuł do palenia i jego produkcja
EP2601455A4 (en) SUN COLLECTOR ARCHITECTURE IN A TEMPORARY ARRANGEMENT
PL2655613T3 (pl) Wytwarzanie cząstek podobnych do wirusa w roślinach
BR112013016641A2 (pt) artigo e método
PL2815004T3 (pl) SPOSÓB WYTWARZANIA MONOKRYSZTAŁÓW lll-N I MONOKRYSZTAŁ lll-N
CO6781482A2 (es) Prevención de la agregación de biomasa en pozos de inyección
BR112013012563A2 (pt) bactéria recombinante e processo de elaboração de glicerol
EP2601454A4 (en) SUN COLLECTOR ARCHITECTURE IN A TEMPORARY ARRANGEMENT
BR112013009579A2 (pt) método e comprimido
IL231001B (en) Methods and compositions for producing capsicum plants with powdery mildew resistance
PL2635104T3 (pl) Rośliny odporne na stres i ich wytwarzanie
FI20096179L (fi) Kerrostettuihin partikkeleihin liittyvä menetelmä ja tuotteet
FI20125048L (fi) Voimala ja voimalan osat
EP2615162A4 (en) METHOD AND DEVICE FOR CULTURE
IL217991A (en) Methods for enhancing the production and consumer traits of plants
SI2588232T1 (sl) Katalitski material in postpoek za njegovo izdelavo
CR20140167A (es) Procedimiento de producción de biomasa y aparato utilizado en dicho procedimiento
EP2749168A4 (en) PLASTERIC COMPOSITION AND ITS USE